Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

Presentation TCT 2016

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples

Presenter: Jihad A. Mustapha, Craig M. Walker, Koen Deloose

November 01, 2016

Presentation TCT 2016

Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study

Presenter: Michael D. Dake, Kenneth Rosenfield, Todd J. Brinton

November 01, 2016

Presentation TCT 2016

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Mehdi H. Shishehbor

November 01, 2016

Presentation TCT 2016

Transcatheter Leaflet Extender for Mitral Valve Repair (MitraPlug)

Presenter: Ted Feldman, Juan F. Granada, Muralidhar Padala

October 30, 2016

Presentation Fellows 2016

Case Discussion: Lower Extremity PAD

Presenter: Sahil A. Parikh

April 17, 2016

Presentation Fellows 2016

Workup and Treatment of Lower-Extremity PAD: When to Treat and the Tools You Need

Presenter: Sahil A. Parikh

April 17, 2016

Presentation TCT 2015

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Presenter: Hans Krankenberg, Lindsay S. Machan, Herbert D. Aronow

October 11, 2015

Presentation TCT 2015

Update on Bioresorbable Scaffolds for PAD

Presenter: Prakash Krishnan, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Gary M. Ansel, Michael R. Jaff, Ori Ben-Yehuda

October 11, 2015

Presentation

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Presenter: Thomas T. Tsai

October 02, 2015

Presentation Aortovascular 2015

The Medical Treatment of the Patient with PAD in the 21st Century

Presenter: Michael R. Jaff

September 18, 2015

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Presentation

Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease

Presenter: S.K. Padala

September 08, 2015

Presentation CCVVC 2015

Economics of Drug-Coated Technology in PAD

Presenter: Mark W. Burket

June 17, 2015

Presentation Fellows 2015

Workup and Treatment of Lower-Extremity PAD: When to Treat and the Tools You Need

Presenter: William A. Gray, Sahil A. Parikh

May 17, 2015

Presentation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Presenter: E.J. Armstrong

April 22, 2015

Presentation

Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac PAD

Presenter: Timothy P. Murphy

March 09, 2015

Presentation

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Presenter: G. Tepe

December 15, 2014

Presentation TCT 2014

Side Cell Population and Valve Function

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Muralidhar Padala

September 15, 2014

Presentation TCT 2014

Featured Presentation: Vorapaxar Safety and Efficacy Results in the FDA-Approved, Stroke-Free MI and PAD Populations

Presenter: Ori Ben-Yehuda, Matthew T. Roe, David J. Moliterno, Marc Bonaca

September 15, 2014

Advertisement

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples

Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Transcatheter Leaflet Extender for Mitral Valve Repair (MitraPlug)

Case Discussion: Lower Extremity PAD

Workup and Treatment of Lower-Extremity PAD: When to Treat and the Tools You Need

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Update on Bioresorbable Scaffolds for PAD

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

The Medical Treatment of the Patient with PAD in the 21st Century

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease

Economics of Drug-Coated Technology in PAD

Workup and Treatment of Lower-Extremity PAD: When to Treat and the Tools You Need

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac PAD

DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD

Side Cell Population and Valve Function

Featured Presentation: Vorapaxar Safety and Efficacy Results in the FDA-Approved, Stroke-Free MI and PAD Populations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content